International Society for Biopharmaceutical Statistics
Nonprofit profile at a glance
- EIN
- 208588581
- IRS 990-EZ coverage
- 2025–2025
- Forms available
- Form 990-EZ 2025, Form 990-N 2024
- Location
- Warrington, PA, USA
- Phone
- 6177687416
- Rating
- 76
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Professional Societies, Associations
Reported finances
- Revenue
- $104,516
- Expenses
- $45,741
- Assets
- $158,331
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
1 person listed
People named in this filing
- Jie Chen (Principle Officer)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
The International Society for Biopharmaceutical Statistics (ISBS) is a globally recognized non-profit statistical organization registered in the United States. Its primary mission is to host biannual symposiums that serve as an international platform for statisticians worldwide to share knowledge, exchange experiences, discuss research findings, and address challenges. Additionally, ISBS aims to enhance and promote the global unification and standardization of statistical practices in the biopharmaceutical industry.
What it reported doing in 2025
In preparation of 2026 8th international symposium in Madrid Spain paid first deposit for the hotel venue
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- Direct operator. The filing allocates 86% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - The filed numbers largely add up and a large share of total spending goes to programs. A relatively small share of available resources goes toward mission work.
Rating breakdown
- Financial Efficiency: 63
- Transparency & Controls: 100
- Sustainability: 87
- Growth: NotEnoughData
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 42.5%; rating input score 43
- Program expense ratio: 97.2%; rating input score 97
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
Sustainability
- Operating margin: 56.2%; rating input score 94; 94th percentile among comparable filings
- Total-asset coverage ratio: 3.46; rating input score 91; 91st percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 74; 74th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 63; 63rd percentile among comparable filings
Growth
- Program expense growth: Limited
- Revenue growth: Limited
- Asset growth: Limited
Details
- Where the money goes: 42.5% of revenue deployed · 97.2% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 3 filed program accomplishments · $44K in reported program spending
- Leadership: top reported pay $0 · 1 people listed
- Consistency: 9 of 9 current checks pass
- Schedules: 3 filed schedules
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- Moderate — Financial Efficiency: Mission deployment rate scored 43/100.